Lopetegui-Lia Nerea, Delasos Lukas, Asad Syed Daniyal, Kumar Manish, Harrison Jonathan S
Department of Medicine University of Connecticut System Farmington CT USA.
Department of Hematology/Oncology, Carole and Ray Neag Comprehensive Cancer Center University of Connecticut System Farmington CT USA.
Clin Case Rep. 2020 Feb 5;8(3):491-497. doi: 10.1002/ccr3.2680. eCollection 2020 Mar.
Primary central nervous system (CNS) marginal zone B-cell lymphoma (MZBCL) arising from the dural meninges is a rare but indolent disease. This malignancy can present in various ways, hence making it difficult to diagnose. Biopsy results dictate an appropriate treatment plan, which commonly consists of a combination of surgical resection, whole brain radiotherapy and systemic therapy.
起源于硬脑膜的原发性中枢神经系统(CNS)边缘区B细胞淋巴瘤(MZBCL)是一种罕见但进展缓慢的疾病。这种恶性肿瘤可以以多种方式呈现,因此难以诊断。活检结果决定合适的治疗方案,该方案通常包括手术切除、全脑放疗和全身治疗的联合应用。